Published on 29 April, 2022

AONM interview with Prof. Dr. Katharina Pachmann (maintrac)

Jan 2020: Personalised Testing of Natural Substances in Order to Support Cancer Cell Apoptosis

This webinar explains how maintrac testing can assist health practitioners in both monitoring treatment and exploring different options of cell apoptosis, using natural substances. Dr Pachmann – AONM Webinar.

ABOUT THE SPEAKER

PROF. DR. MED. KATHARINA PACHMANN is the founder of the Maintrac system of identifying circulating cancer cells in a “liquid biopsy”, and runs the Maintrac laboratory in Bayreuth, Germany, together with Dr. Ulrich Pachmann and a staff of 45. As both a medical doctor and research scientist, she has been conducting studies in this field and refining related techniques for over two decades, and has authored over a hundred scientific publications on the technique (https://aonm.org/scientific-articles-and-studies/)

She received her PhD from the Institute for Haematology at the Society for Radiological Research, Munich, and worked as the Head of the Department of Experimental Haematology and Oncology, Friedrich Schiller-University, Jena, for many years. She is a visiting scientist at the University Clinic, Graz, Austria, and has also served in the same capacity at MD Anderson Cancer Center Houston Texas Section of Molecular Haematology and Therapy.

CLICK HERE for background information on this lab and its tests.

AONM for Cancer Monitoring (maintrac): Patients or their Practitioners can order maintrac easily from AONM.